USRE35192E - Post-surgical anesthesia at a continuous and progressively decreasing administration rate - Google Patents
Post-surgical anesthesia at a continuous and progressively decreasing administration rate Download PDFInfo
- Publication number
- USRE35192E USRE35192E US08/319,148 US31914894A USRE35192E US RE35192 E USRE35192 E US RE35192E US 31914894 A US31914894 A US 31914894A US RE35192 E USRE35192 E US RE35192E
- Authority
- US
- United States
- Prior art keywords
- catheter
- syringe
- surgical site
- rate
- medication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003247 decreasing effect Effects 0.000 title claims abstract description 20
- 206010002091 Anaesthesia Diseases 0.000 title claims abstract description 11
- 230000037005 anaesthesia Effects 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 53
- 229940079593 drug Drugs 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000003444 anaesthetic effect Effects 0.000 claims abstract description 14
- 230000001105 regulatory effect Effects 0.000 claims abstract description 6
- 239000007924 injection Substances 0.000 claims description 15
- 238000002347 injection Methods 0.000 claims description 15
- 208000002193 Pain Diseases 0.000 claims description 7
- 230000036407 pain Effects 0.000 claims description 7
- 208000002847 Surgical Wound Diseases 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims 21
- 230000036592 analgesia Effects 0.000 claims 8
- 230000001276 controlling effect Effects 0.000 claims 4
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 6
- 230000007423 decrease Effects 0.000 abstract description 4
- 238000004513 sizing Methods 0.000 abstract description 2
- 238000001802 infusion Methods 0.000 description 3
- 208000004550 Postoperative Pain Diseases 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- SIEYLFHKZGLBNX-UHFFFAOYSA-N bupivacaine hydrochloride (anhydrous) Chemical compound [Cl-].CCCC[NH+]1CCCCC1C(=O)NC1=C(C)C=CC=C1C SIEYLFHKZGLBNX-UHFFFAOYSA-N 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940106885 marcaine Drugs 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012899 standard injection Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1454—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons spring-actuated, e.g. by a clockwork
Definitions
- This invention is related in general to the field of drug infusions and, in particular, to the area of administration of post-operative anesthesia.
- the invention provides a novel technique and equipment to inject liquid anesthetics directly into the surgical site on a continuous basis.
- Post-operative pain normally requires the injection of anesthetic medication into the area affected by the surgical procedure in order to alleviate the patient's discomfort and facilitate a successful recovery.
- care providers inject a liquid anesthetic directly into the surgical site for a number of days after the operation. This procedure necessitates a new needle puncture in an already sensitive area with each administration, with the obvious result of pain exacerbation and an increased potential for infection.
- post-operative pain can be alleviated with the administration of narcotics, but this approach is generally not favored because of their side effects.
- One objective of this invention is the development of a device for the administration of post-operative anesthesia locally and through a single injection site. This is obtained by providing a catheter that is introduced into the surgical wound and is used as the sole channel for infusing the required amount of pain relieving medication.
- Another objective of the invention is an apparatus that dispenses the medication on a continuous basis.
- this device involves a spring-loaded syringe capable of holding the entire dosage of anesthetic required to be infused during the course of treatment and of delivering it continuously as a result of constant pressure applied by a spring on the syringe plunger.
- a further goal of the invention is the gradual decrease of the rate of delivery of anesthetic according to a predetermined administration schedule. Therefore, the rate of flow out of the syringe is controlled by a specially designed length of micro-bore tubing and a variable pressure spring that result in the desired rate of delivery.
- Yet another goal of the invention is a unit that can be set up as part of the post-operative procedure and left in place during the entire period of administration.
- the apparatus includes a catheter placement needle to provide access to the surgical site through a single procedure, and an injection port for charging the spring-loaded syringe with the total dosage of required medication.
- a final objective is the easy and economical manufacture of the device according to the above stated criteria. This is achieved by using commercially available components and materials, modified only to the extent necessary to fit the requirements of the invention.
- the present invention describes an apparatus for administering post-operative anesthesia directly to the surgical site through a catheter introduced into the site during the post-operative procedure.
- the flow of medication into the catheter is regulated by a micro-bore cannula that insures delivery at very small rates.
- the plunger of a spring-loaded syringe creates the pressure that causes the medication to flow through the cannula and catheter into the wound. Because of the spring's nonlinear characteristics within the range of stroke of the plunger, the pressure exerted on the liquid gradually decreases with the expansion of the spring.
- FIG. 1 is a schematic representation of the apparatus of this invention as used to administer medication to a patient.
- FIG. 2 is a cross-section of an elevational view of one embodiment of the spring-loaded syringe shown in FIG. 1.
- FIG. 3 is a representative plot of the cumulative volume of medication administered by the apparatus of the invention as a function of time.
- This invention consists of the application of simple mechanical principles in combination with known structural components to achieve a practical and economical design for an infusion device with the properties described above.
- the main point of the invention lies in the recognition of the advantages involved with the continuous administration of post-operative anesthesia and the fact that it can be achieved in an optimal manner by gradually reducing the delivery rate according to a desired, predetermined schedule.
- FIG. 1 illustrates the apparatus 10 of this invention with its several components assembled for use.
- a spring-loaded syringe 20, integrally connected through its tip 26 to standard medical tubing 31, is used both as reservoir and pump.
- a 50 cc syringe is employed because that capacity corresponds with the normal requirements of total anesthetic administration during the post-operative period.
- the plunger 22 of the syringe is connected in working relationship with a spring 30 that exerts pressure in the direction of discharge.
- the stopper 23 of the plunger 22 is pushed in an outward direction in the barrel 24, and the spring 30 is compressed and loaded into a charged position for exerting pressure on the liquid.
- the spring pressure causes the medication to flow out of the syringe continuously until the syringe becomes empty at the end of the plunger's stroke.
- the pressure exerted by an ideal spring within its normal operating range is directly proportional to its elastic force; this, in turn, is directly proportional to the spring's linear compression.
- the pressure exerted on the plunger's stopper decreases approximately linearly as the spring 30 expands, producing a progressively decreasing flow rate of medication out of the syringe.
- the medication tubing 31 attached to the syringe is equipped with a luer-lock or similar fitting 32 for connection with the other components of the invention.
- a flow controller 36 Directly downstream is an injection port 34 mounted on a Y fitting, provided for use in the process of charging the syringe 20 with medication, as mentioned above, followed by a flow controller 36.
- the flow controller consists of a micro-bore cannula of a specific inside diameter and length to provide the necessary flow restriction and pressure drop for producing, in cooperation with the syringe 20, the desired flow rate of anesthetic to the patient.
- the flow controller 36 is obviously placed downstream of the injection port 34 to avoid interference with the process of charging the syringe.
- the flow controller 36 is connected to a medication catheter 38 that is provided for placement into the surgical site S.
- a hypodermic needle 40 is provided for use during the procedure of placing the catheter 38 into the site S through a puncture P in the skin of the patient.
- FIG. 3 illustrates in graphical form the cumulative volume of medication administered to the patient in a typical run.
- the appropriate amount of medication is loaded into the spring-loaded syringe 20 with a regular injection syringe and needle through the port 34 according to standard safety procedure to avoid air entrainment.
- the point of the hypodermic needle 40 is pushed from inside the surgical wound S to penetrate away from the site to be medicated, and then pushed outside through the skin at a point P as far away from the site as possible.
- the end of the catheter 38 is inserted into the needle and threaded through it all the way to the surgical site, as illustrated in FIG. 1. Then, the needle is pulled out leaving the catheter in place in the surgical site, carefully avoiding introducing it into the epidural space.
- the syringe 20 is connected to the catheter through the flow controller 36 for the delivery of the medication.
- the catheter can safely remain in place for up to three days, which is considered a normal period of post-operative anesthetic treatment.
- the spring-loaded syringe With the exception of the spring-loaded syringe, all the components described above constitute standard medical equipment currently available in commerce. For example, a standard injection port and luer-lock fittings were used; the medication tubing was medical grade flexible PVC tubing; the catheter was 8 inch long and 22 gauge; and the placement needle was a standard 18 gauge hypodermic needle.
- the spring-loaded syringe was obtained by mounting a standard spring in a regular syringe so that it produced the necessary pressure against the plunger's stopper, as illustrated in FIG. 2.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/319,148 USRE35192E (en) | 1990-11-13 | 1994-10-06 | Post-surgical anesthesia at a continuous and progressively decreasing administration rate |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/611,976 US5078679A (en) | 1990-11-13 | 1990-11-13 | Post-surgical anesthesia at a continuous and progressively decreasing administration rate |
| US7863293A | 1993-06-21 | 1993-06-21 | |
| US08/319,148 USRE35192E (en) | 1990-11-13 | 1994-10-06 | Post-surgical anesthesia at a continuous and progressively decreasing administration rate |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/611,976 Reissue US5078679A (en) | 1990-11-13 | 1990-11-13 | Post-surgical anesthesia at a continuous and progressively decreasing administration rate |
| US7863293A Continuation | 1990-11-13 | 1993-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USRE35192E true USRE35192E (en) | 1996-03-26 |
Family
ID=26760772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/319,148 Expired - Lifetime USRE35192E (en) | 1990-11-13 | 1994-10-06 | Post-surgical anesthesia at a continuous and progressively decreasing administration rate |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USRE35192E (en) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| US6106858A (en) | 1997-09-08 | 2000-08-22 | Skyepharma, Inc. | Modulation of drug loading in multivescular liposomes |
| US6306432B1 (en) | 1997-09-08 | 2001-10-23 | Chiron Corporation | High and low load formulations of IGF-I in multivesicular liposomes |
| USD453830S1 (en) | 2001-05-21 | 2002-02-19 | Mckinley Medical L.L.L.P. | Infusion pump |
| US6348043B1 (en) | 1998-12-29 | 2002-02-19 | Mckinley Medical, Lllp | Multi-dose infusion pump providing minimal flow between doses |
| US20020039596A1 (en) * | 1997-11-14 | 2002-04-04 | Hartoun Hartounian | Production of multivesicular liposomes |
| US6802823B2 (en) | 2001-08-22 | 2004-10-12 | Breg, Inc. | Medication delivery system having selective automated or manual discharge |
| WO2003082371A3 (en) * | 2002-03-26 | 2006-02-02 | Becton Dickinson Co | Multi-stage fluid delivery device and method |
| US20060078606A1 (en) * | 1997-09-18 | 2006-04-13 | Skyepharma Inc. | Sustained-release liposomal anesthetic compositions |
| US20080097317A1 (en) * | 2006-08-25 | 2008-04-24 | Jeffery Alholm | Infusion pump |
| US20100100038A1 (en) * | 2008-10-15 | 2010-04-22 | Symbios Medical Products, Llc | Electronic flow control |
| US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12151024B2 (en) | 2021-01-22 | 2024-11-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12156940B1 (en) | 2024-05-20 | 2024-12-03 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251468B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251472B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12285419B2 (en) | 2021-10-14 | 2025-04-29 | Pacira Pharmaceuticals, Inc. | Bupivacaine multivesicular liposome formulations and uses thereof |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598119A (en) * | 1970-02-02 | 1971-08-10 | Charles A White | Continuous paracervical anesthesia method and device |
| US3854477A (en) * | 1973-04-06 | 1974-12-17 | S Smith | Apparatus and method for the application of a continuous somatic nerve block |
| US4381006A (en) * | 1980-11-10 | 1983-04-26 | Abbott Laboratories | Continuous low flow rate fluid dispenser |
| US4597754A (en) * | 1978-11-08 | 1986-07-01 | Minnesota Mining And Manufacturing Company | Long capillary tube hose assembly for fluid dispensing device |
| US4813926A (en) * | 1986-07-02 | 1989-03-21 | Sherwood Medical Company | Medical suction device with air vent and fixed restrictor |
| US4813937A (en) * | 1986-05-07 | 1989-03-21 | Vaillancourt Vincent L | Ambulatory disposable infusion delivery system |
| US4863429A (en) * | 1987-06-30 | 1989-09-05 | Baldwin Brian E | Syringe driver/syringe/tube connecting set fluid delivery arrangement, and tube connecting sets therefor |
| US4874386A (en) * | 1986-12-05 | 1989-10-17 | Sta-Set Corporation | Fluid dispensing device |
| US4966585A (en) * | 1988-05-31 | 1990-10-30 | Gangemi Ronald J | Infusion apparatus |
| US4997420A (en) * | 1989-12-28 | 1991-03-05 | Lefevre Robert J | Portable drug delivery device including pump with tapered barrel |
| US5069668A (en) * | 1990-07-12 | 1991-12-03 | Boydman Scott A | Patient controlled analgesia system |
| US5084021A (en) * | 1990-11-02 | 1992-01-28 | Baldwin Brian E | Patient controlled infusion apparatus and method |
| US5106376A (en) * | 1989-07-07 | 1992-04-21 | B. Braun Melsungen Ag | Anaesthesia set |
-
1994
- 1994-10-06 US US08/319,148 patent/USRE35192E/en not_active Expired - Lifetime
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598119A (en) * | 1970-02-02 | 1971-08-10 | Charles A White | Continuous paracervical anesthesia method and device |
| US3854477A (en) * | 1973-04-06 | 1974-12-17 | S Smith | Apparatus and method for the application of a continuous somatic nerve block |
| US4597754A (en) * | 1978-11-08 | 1986-07-01 | Minnesota Mining And Manufacturing Company | Long capillary tube hose assembly for fluid dispensing device |
| US4381006A (en) * | 1980-11-10 | 1983-04-26 | Abbott Laboratories | Continuous low flow rate fluid dispenser |
| US4813937A (en) * | 1986-05-07 | 1989-03-21 | Vaillancourt Vincent L | Ambulatory disposable infusion delivery system |
| US4813926A (en) * | 1986-07-02 | 1989-03-21 | Sherwood Medical Company | Medical suction device with air vent and fixed restrictor |
| US4874386A (en) * | 1986-12-05 | 1989-10-17 | Sta-Set Corporation | Fluid dispensing device |
| US4863429A (en) * | 1987-06-30 | 1989-09-05 | Baldwin Brian E | Syringe driver/syringe/tube connecting set fluid delivery arrangement, and tube connecting sets therefor |
| US4966585A (en) * | 1988-05-31 | 1990-10-30 | Gangemi Ronald J | Infusion apparatus |
| US5106376A (en) * | 1989-07-07 | 1992-04-21 | B. Braun Melsungen Ag | Anaesthesia set |
| US4997420A (en) * | 1989-12-28 | 1991-03-05 | Lefevre Robert J | Portable drug delivery device including pump with tapered barrel |
| US5069668A (en) * | 1990-07-12 | 1991-12-03 | Boydman Scott A | Patient controlled analgesia system |
| US5084021A (en) * | 1990-11-02 | 1992-01-28 | Baldwin Brian E | Patient controlled infusion apparatus and method |
Cited By (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| US6428529B1 (en) * | 1995-07-14 | 2002-08-06 | Skyepharma Inc. | Epidural administration of therapeutic compounds with sustained rate of release |
| US6106858A (en) | 1997-09-08 | 2000-08-22 | Skyepharma, Inc. | Modulation of drug loading in multivescular liposomes |
| US6306432B1 (en) | 1997-09-08 | 2001-10-23 | Chiron Corporation | High and low load formulations of IGF-I in multivesicular liposomes |
| US20060078606A1 (en) * | 1997-09-18 | 2006-04-13 | Skyepharma Inc. | Sustained-release liposomal anesthetic compositions |
| US9205052B2 (en) | 1997-09-18 | 2015-12-08 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| US9192575B2 (en) | 1997-09-18 | 2015-11-24 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| US8834921B2 (en) | 1997-09-18 | 2014-09-16 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| US8182835B2 (en) | 1997-09-18 | 2012-05-22 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| US20020039596A1 (en) * | 1997-11-14 | 2002-04-04 | Hartoun Hartounian | Production of multivesicular liposomes |
| US9585838B2 (en) | 1997-11-14 | 2017-03-07 | Pacira Pharmaceuticals, Inc. | Production of multivesicular liposomes |
| US6348043B1 (en) | 1998-12-29 | 2002-02-19 | Mckinley Medical, Lllp | Multi-dose infusion pump providing minimal flow between doses |
| USD453830S1 (en) | 2001-05-21 | 2002-02-19 | Mckinley Medical L.L.L.P. | Infusion pump |
| US7309333B2 (en) * | 2001-08-22 | 2007-12-18 | Breg, Inc. | Medication delivery system having selective automated or manual discharge |
| US20050033262A1 (en) * | 2001-08-22 | 2005-02-10 | Mason Jeffrey T. | Medication delivery system having selective automated or manual discharge |
| US6802823B2 (en) | 2001-08-22 | 2004-10-12 | Breg, Inc. | Medication delivery system having selective automated or manual discharge |
| WO2003082371A3 (en) * | 2002-03-26 | 2006-02-02 | Becton Dickinson Co | Multi-stage fluid delivery device and method |
| US7214221B2 (en) | 2002-03-26 | 2007-05-08 | Becton, Dickinson And Company | Multi-stage fluid delivery device and method |
| AU2003218371B2 (en) * | 2002-03-26 | 2008-06-12 | Becton, Dickinson And Company | Multi-stage fluid delivery device and method |
| US20080097317A1 (en) * | 2006-08-25 | 2008-04-24 | Jeffery Alholm | Infusion pump |
| US20100100038A1 (en) * | 2008-10-15 | 2010-04-22 | Symbios Medical Products, Llc | Electronic flow control |
| US11179336B1 (en) | 2021-01-22 | 2021-11-23 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11925706B2 (en) | 2021-01-22 | 2024-03-12 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11185506B1 (en) | 2021-01-22 | 2021-11-30 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11304904B1 (en) | 2021-01-22 | 2022-04-19 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11311486B1 (en) | 2021-01-22 | 2022-04-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11426348B2 (en) | 2021-01-22 | 2022-08-30 | Pacira Pharmaceuticals, Inc. | Compositions of bupivacaine multivesicular liposomes |
| US11452691B1 (en) | 2021-01-22 | 2022-09-27 | Pacira Pharmaceuticals, Inc. | Compositions of bupivacaine multivesicular liposomes |
| US11819575B2 (en) | 2021-01-22 | 2023-11-21 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11819574B2 (en) | 2021-01-22 | 2023-11-21 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12144890B2 (en) | 2021-01-22 | 2024-11-19 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12151024B2 (en) | 2021-01-22 | 2024-11-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12296047B2 (en) | 2021-01-22 | 2025-05-13 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12178909B1 (en) | 2021-01-22 | 2024-12-31 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12285419B2 (en) | 2021-10-14 | 2025-04-29 | Pacira Pharmaceuticals, Inc. | Bupivacaine multivesicular liposome formulations and uses thereof |
| US12246092B1 (en) | 2024-05-20 | 2025-03-11 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251468B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251472B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12280149B1 (en) | 2024-05-20 | 2025-04-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12156940B1 (en) | 2024-05-20 | 2024-12-03 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12318483B1 (en) | 2024-05-20 | 2025-06-03 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12370142B1 (en) | 2024-05-20 | 2025-07-29 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5078679A (en) | Post-surgical anesthesia at a continuous and progressively decreasing administration rate | |
| USRE35192E (en) | Post-surgical anesthesia at a continuous and progressively decreasing administration rate | |
| DE60126325T2 (en) | DEVICE FOR THE TRANSCUTANEOUS DISPOSAL OF MEDICAMENTS | |
| CN100402100C (en) | Large loading dose device and method | |
| US8372045B2 (en) | Controlled-volume infusion device | |
| US6656159B2 (en) | Dispenser for patient infusion device | |
| US6293922B1 (en) | Apparatus and method for guiding and limiting access by hypodermic needles to septum of a human implantable medical treatment device | |
| US4857056A (en) | Auto-flush syringe pump | |
| US6494867B1 (en) | Medical device | |
| US20040092865A1 (en) | Transcutaneous delivery means | |
| US20040030281A1 (en) | Integrated infusion and aspiration system and method | |
| EP1467782B1 (en) | Implantable infusion pump | |
| AU2010207762A1 (en) | Transcutaneous delivery means | |
| AU2024203640A1 (en) | Syringe Infusion Devices And Systems For Delivery Of Active Agents | |
| US20220370714A1 (en) | Tissue saturation responsive rapid automatically variable flow rate infusion system | |
| CN2892107Y (en) | Disposable micro relieving pain pump | |
| Lubenow et al. | Intraspinal narcotics for treatment of cancer pain | |
| Gianino et al. | Implantable Delivery Systems | |
| HK1070599B (en) | Large volume bolus device and method | |
| CN1814312A (en) | Disposable micro analgesic pump |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: H. WILLIAM REESE, D.P.M., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SGARLATO LABORATORIES, INC., A CORP. OF CA;REEL/FRAME:008535/0263 Effective date: 19960816 |
|
| AS | Assignment |
Owner name: REESE, H. WILLIAM, ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SGARLATO LABORATORIES, INC., A CALIFORNIA CORPORATION;REEL/FRAME:008296/0187 Effective date: 19960816 |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |